Over $400 million in capital raises tracked year-to-date; M&A activity accelerating since end of third quarter 2016.
Summary for the Week Ended March 17, 2017
- Announcements: 22
- Capital Raises: 7
- M&A Transactions: 11
- Capital Raise & Going-Public Transaction:
1
- Joint Venture: 1
- New Cannabis Fund: 1
- New Stock Listing: 1
- Capital Raises: 7
- Year-over-Year:
- 3 capital raises closed this week for a total
of $11.2 million ($3.7 million average) compared to 3 raises closed for a
total of $7.3 million ($2.5 million average) this week last year.
- 4 M&A deals closed this week compared to
6 deals closed this week last year.
- 3 capital raises closed this week for a total
- We have tracked over $400 million in capital
raises closed by
cannabis companies year-to-date, with the top sectors being:
- Cultivation & Retail: $169.8 million
- Biotech/Pharma: $109.8 million
- Investments/M&A: $40.6 million
- Cultivation & Retail: $169.8 million
- M&A activity in Investments/M&A sector
follows trend of accelerating M&A activity in overall cannabis sector:
- We tracked an average of 1.4 deals closed per
week in the first three quarters of 2016 compared to 3.3 deals closed per
week from the start of the fourth quarter of 2016 to date in 2017.
- We tracked an average of 1.4 deals closed per
Capital Raises
- MGC Pharmaceuticals Ltd. (ASX: MXC) raised AUD $10 million to
fast-track the commercialization of its growth objectives, including the research
and development of pharmaceutical-grade products.
- The Hydropothecary Corp. raised C$2.5 million in a private placement
pursuant to the exercise of a right which a shareholder had to acquire such
shares before the completion of a going public transaction.
- Cannabis marketing platform Baker raised $1.6 million to fund
its continued growth.
Week Ended 3.17.17 – Capital Raises by Sector
Mergers & Acquisitions
- Namaste Technologies,
Inc. (CSE: N) acquired Australian Vaporizers PTY Ltd., an Australia-based e-commerce
site for vaporizers and other smoking accessories.
- American Housing Income
Trust, Inc. (OTCQB:
AHIT) acquired IX Biotechnology, Inc., a producer of cannabidiol
(CBD) oil, as its foray into the cannabis industry.
- Grow Condos, Inc. (OTCQB:
GRWC) acquired Lake Selmac Resort & RV Park, an RV park and campground
located in Selma, Oregon.
- The Canadian Bioceutical
Corp. (CSE:
BCC) acquired various assets related to the medical cannabis industry
from PerkAZ Property LLC, an Arizona-registered company active in the
cannabis space
.
Week Ended 3.17.17 – M&A Deals by Sector
Summary of Year-to-Date (YTD) Transactions
Capital Raises
- We have tracked 74 capital raises totaling $401.0
million.
- Public versus Private:
- Public companies: 54 raises totaling $377.9
million
- Private companies: 20 raises totaling $23.1
million
- Public companies: 54 raises totaling $377.9
- Equity versus Debt:
- Equity: 58 raises totaling $373.0 million
- Debt: 16 raises totaling $28.0 million
- Equity: 58 raises totaling $373.0 million
YTD Capital Raises by Week
YTD Capital Raises by Sector
Mergers & Acquisitions
- We have tracked 35 M&A transactions.
- 31 deals by public companies
- 4 deals by private companies
- 31 deals by public companies
- M&A activity in Agriculture Technology sector
points to continued development and implementation of more advanced growing
technologies as cultivators seek to maximize efficiency and to lower costs
amid pricing pressure.
- Activity in Investments/M&A sector follows
trend of accelerating M&A activity in cannabis sector
- Average of 1.4 deals closed per week in first
three quarters of 2016 compared to 3.3 deals closed per week from the start
of the fourth quarter of 2016 to date in 2017.
- Average of 1.4 deals closed per week in first
YTD M&A Deals by Week
YTD M&A Deals by Sector
Transactions by Sector for Week Ended March 17, 2017
Capital Raises
Agriculture Technology
GrowGeneration Secures $1,650,000 in Capital from Merida Capital Partners to Continue to Fuel Growth
Biotech/Pharma
Vitality Biopharma, Inc. Enters into Securities Purchase Agreement
MGC Pharmaceuticals Closes Oversubscribed AUD $10M Placement
Cultivation & Retail
THC Announces C$10,000,000 Capital Commitment
Maple Leaf Seeks New C$6M Financing and Terminates Previous Offering
Software/Media
Cannabis Marketing Platform, Baker, Gets $1.6M in Added Funding
Metatron $1,000,000 Reg A Capital Raise to fund Cannabis & Vaporize, a Secure Chat App
Mergers & Acquisitions
Consulting Services
BCC Completes Acquisition of New Cannabis Assets
Consumption Devices
Namaste Closes Acquisition of Australian Vaporizers
Cultivation & Retail
Matica Announces Letter of Intent to Acquire a 70% Interest in a Review Stage Marijuana Producer Applicant
CaliPharms and Pacific Cannabis Growers Execute Acquisition Term Sheet
Infused Products & Extracts
Laguna Blends to Acquire 100% Stake in a Global Cannabis Leader with Unaudited Annualized Sales of Approximately $12,000,000 USD
Laguna Blends Clarifies Previous Disclosure to Acquire 100% Stake in a Global Cannabis Leader
American Housing Income Trust Announces Acquisition Of Cannabidol (CBD) Company IX Biotechnology
Golden Leaf Signs Binding Letter of Intent for Strategic Acquisition in Canada*
Investments/M&A
Invictus MD Announces Completion of its Commitment to Acquire 33.33% of Licensed Producer AB Laboratories Inc.
Miscellaneous Ancillary
CB Scientific (CBSC) Purchases Marutronics LLC, Inventor of Medical Cannabis Delivery Device — CB Scientific to Manufacture Proprietary Thermo-Responsive Cannabinoid Delivery Device for Global Delivery
Real Estate
Grow Condos, Inc., Closes Acquisition Lake Selmac Resort & RV Park
Capital Raise & Going-Public Transaction
Cultivation & Retail
The Hydropothecary Corporation Announces Closing of Qualifying Transaction
Joint Venture
Infused Products & Extracts
Village Tea Company Announces Partnership with Green Roads Wellness
New Cannabis Fund
Investments/M&A
Green Leaf Investment Fund to Launch $10.2 Million Regulation A+ Cannabis Real Estate Offering Through CrowdVest’s Platform
New Stock Listing
Agriculture Technology
The Hydroponics Company to List on ASX
To Learn More About the Viridian Cannabis Deal Tracker, Contact:
Harrison Phillips
Viridian Capital Advisors, LLC
(212) 209-3086
[email protected]
*Disclaimers
The information contained herein is for informational purposes and is not intended as a research report. It should not be construed as Viridian recommending investment in cannabis companies or as a solicitation to buy or sell any security or engage in a particular investment strategy. Investment in cannabis companies entails substantial risk. Before acting on any information, you should consider whether it is suitable for your particular circumstances and consult all available material, and, if necessary, seek professional advice.
Viridian Capital Advisors and its affiliates, as well as their respective partners, directors, shareholders, and employees, may have a position in the securities mentioned herein and may make purchases and/or sales from time to time. Viridian Capital Advisors, through broker-dealer services provided by Pickwick Capital Partners, LLC, Member FINRA/SIPC, may act, or may have acted in the past, as a financial advisor for certain of the companies mentioned herein and may receive, and may have received, a remuneration for their services from those companies.
About the Viridian Cannabis Deal Tracker
The Viridian Cannabis Deal Tracker monitors capital raise, mergers & acquisition, joint venture, and licensing activity for both public and private companies in the legal cannabis industry across 12 key sectors, including Agriculture Technology, Biotech/Pharma, Consulting Services, Consumption Devices, Cultivation & Retail, Hemp, Investments/M&A (Holding Companies), Infused Products & Extracts, Miscellaneous Ancillary, Physical Security, Real Estate, and Software/Media.
Leveraging more than 3 years of data collection, segmentation, and analysis, the Viridian Cannabis Deal Tracker supports smart decision-making by providing sector-specific actionable intelligence and trend analysis in regard to issuers, investors, acquirers, valuations, deal structures, and deal terms.
The above information whether in part or in its entirety neither constitutes an offer nor makes any recommendation to buy or sell any securities.
About Viridian Capital Advisors, LLC
Viridian Capital Advisors (www.viridianca.com) is a financial and strategic advisory firm dedicated to the cannabis market. We are a data- and market intelligence-driven firm that provides investment banking, M&A, corporate development, and investor relations services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, FINRA/SIPC provides capital and M&A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team’s decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.